NEW YORK, Dec. 28, 2015
For the first year ever, global M&A volume in 2015 surpassed $5 trillion, according to Dealogic data.
This record-setting volume breaks the previous record of $4.6 trillion set in 2007, by 9%. There were 10 $50bn+ M&A transactions announced in 2015 worth a combined $798.9bn. That’s five deals more than the previous record high activity set in 1998, 1999, and 2014. US targeted M&A ($2.5tr) accounts for half of 2015 volume and seven of the top 10 transactions.
Healthcare ($723.7bn) and Technology ($713.1bn) were the leading sectors. The biggest deals announced in 2015 were Pfizer and Allergan’s pending $160bn merger, followed by Anheuser-Busch InBev’s $117.4bn bid for SABMiller, two of only eight $100bn+ transactions announced on record.
Dealogic offers integrated content, analytics, and technology via targeted products and services to top financial firms worldwide. Whether working in capital markets, sales and trading, banking, or compliance, firms rely on the Dealogic platform to connect and more effectively identify opportunities, execute deals, and manage risk. With more than 30 years’ experience and a deep understanding of financial markets, Dealogic is a global trusted partner.